Lv2
110 积分 2022-07-22 加入
GPCR drug discovery: new agents, targets and indications
2天前
已完结
Update on the treatment navigation for functional cure of chronic hepatitis B: expert consensus 2.0
26天前
已完结
Recent advances in trophoblast cell‐surface antigen 2 targeted therapy for solid tumors
1个月前
已完结
A pathology atlas of the human cancer transcriptome
1个月前
已完结
Synthetic lethal strategies for the development of cancer therapeutics
2个月前
已完结
Mapping the effectiveness and risks of GLP-1 receptor agonists
2个月前
已完结
Toxicology profile of a novel GLP1 receptor biased agonist-SAL0112 in nonhuman primates
3个月前
已完结
Glp1r-Lepr coexpressing neurons modulate the suppression of food intake and body weight by a GLP-1/leptin dual agonist
3个月前
已完结
Efficacy and safety of immune checkpoint inhibitors for individuals with advanced EGFR-mutated non-small-cell lung cancer who progressed on EGFR tyrosine-kinase inhibitors: a systematic review, meta-analysis, and network meta-analysis
3个月前
已完结
The targeted protein degradation landscape
4个月前
已完结
皖公网安备34019202002308
